TY  - GEN
AU  - Hochberg,Marc C
AU  - Tive,Leslie A
AU  - Abramson,Steven B
AU  - Vignon,Eric
AU  - Verburg,Kenneth M
AU  - West,Christine R
AU  - Smith,Michael D
AU  - Hungerford,David S
TI  - When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
SN  - 2326-5205
PY  - 2016///0614
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Arthroplasty, Replacement
KW  - statistics & numerical data
KW  - Chronic Pain
KW  - drug therapy
KW  - Clinical Trials, Phase II as Topic
KW  - Clinical Trials, Phase III as Topic
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Low Back Pain
KW  - Osteoarthritis
KW  - Osteonecrosis
KW  - chemically induced
KW  - Proportional Hazards Models
KW  - Randomized Controlled Trials as Topic
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/art.39492
ER  -